2,3-Dimethoxy-N-<1-(phenylmethyl)-4-piperidinyl>benzamide hydrochloride | 92138-58-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 2,3-Dimethoxy-N-<1-(phenylmethyl)-4-piperidinyl>benzamide hydrochloride
• 英文别名: 2,3-dimethoxy-N-(1-benzylpiperidin-4-yl) benzamide；2,3-dimethoxy-N-(1-benzyl-4-piperidinyl)benzamide；2,3-dimethoxy-N-(1-benzylpiperidin-4-yl)benzamide；N-(1-benzylpiperidin-4-yl)-2,3-dimethoxybenzamide
• CAS: 92138-58-4
• 化学式: C₂₁H₂₆N₂O₃
• mdl: MFCD03080168
• 分子量: 354.449
• InChiKey: CFOLDWHTVLAWTI-UHFFFAOYSA-N

物化性质

• 沸点：
  484.5±45.0 °C(Predicted)
• 密度：
  1.17±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  26
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  50.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2,3-Dimethoxy-N-<1-(phenylmethyl)-4-piperidinyl>benzamide hydrochloride 在 palladium dihydroxide 、 甲烷 氢气 作用下， 以 乙醇 为溶剂， 反应 72.0h， 生成 2,3-dimethoxy-N-(piperidin-4-yl)benzamide
  参考文献：
  名称：

  Fluorine-18 labeled benzamides for studying the dopamine D2 receptor with positron emission tomography

  摘要：

  Two series of (N-benzylpiperidin-4-yl)- and (9-azabicyclo[3.3.1]nonan-3beta-yl)benzamides were prepared, and in vitro binding assays were used to measure the affinity of these compounds for dopamine D2, dopamine D3, serotonin 5-HT2, and alpha2-adrenergic receptors. The results of these studies indicated compounds 23, 26b, and 34 have the selectivity needed for in vivo studies of the D2 (and possibly D3) receptors. F-18-Labeled analogues of 23, 26b and 34 were prepared by N-alkylation of the corresponding desbenzyl precursors with [F-18]-4-fluorobenzyl iodide. Preliminary in vivo studies demonstrated that [F-18]-23 and [F-18]-26b are suitable candidates for further evaluation in positron emission tomography imaging studies. The slow rate of washout of [F-18]-34 from nondopaminergic regions and its comparatively high lipophilicity indicates that this compound may not be suitable for imaging studies because of a high level of nonspecific binding.

  DOI：

  10.1021/jm00075a028
• 作为产物：
  描述：

  2,3-二甲氧基苯甲酸 在 氯化亚砜 、 N,N-二甲基甲酰胺 作用下， 以 氯仿 、 甲苯 为溶剂， 反应 2.5h， 生成 2,3-Dimethoxy-N-<1-(phenylmethyl)-4-piperidinyl>benzamide hydrochloride
  参考文献：
  名称：

  Potential antipsychotic agents. 6. Synthesis and antidopaminergic properties of substituted N-(1-benzyl-4-piperidinyl)salicylamides and related compounds. QSAR based design of more active members

  摘要：

  DOI：

  10.1016/0223-5234(90)90145-s

文献信息

• Structure–Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)
  作者：Lars Jørgensen、Anas Al-Khawaja、Stefanie Kickinger、Stine B. Vogensen、Jonas Skovgaard-Petersen、Emil Rosenthal、Nrupa Borkar、Rebekka Löffler、Karsten K. Madsen、Hans Bräuner-Osborne、Arne Schousboe、Gerhard F. Ecker、Petrine Wellendorph、Rasmus P. Clausen

  DOI：10.1021/acs.jmedchem.7b00924

  日期：2017.11.9

  4-dichlorobenzamide 5 (BPDBA) is a noncompetitive inhibitor of the betaine/GABA transporter 1 (BGT1). We here report the synthesis and structure–activity relationship of 71 analogues. We identify 26m as a more soluble 2,4-Cl substituted 3-pyridine analogue with retained BGT1 activity and an improved off-target profile compared to 5. We performed radioligand-based uptake studies at chimeric constructs between BGT1

  N -(1-Benzyl-4-piperidinyl)-2,4-dichlorobenzamide 5 (BPDBA) 是一种甜菜碱/GABA 转运蛋白 1 (BGT1) 的非竞争性抑制剂。我们在这里报告了 71 种类似物的合成和构效关系。我们将26m鉴定为更易溶解的 2,4-Cl 取代的 3-吡啶类似物，与5相比具有保留的 BGT1 活性和改善的脱靶特征. 我们在 BGT1 和 GAT3 之间的嵌合构建体上进行了基于放射性配体的摄取研究、定点突变转运蛋白实验以及基于新确定的人血清素转运蛋白 (hSERT) 的 X 射线晶体结构的 BGT1 同源模型中的计算对接。在这些实验的基础上，我们提出了一种结合模式，该模式涉及 BGT1 中变构位点中 TM10 内的残基，该位点对应于 hSERT 晶体结构所揭示的变构结合袋。我们的研究为 BGT1 中提出的变构结合袋提供了初步见解，该袋可容纳一系列新型非竞争性抑制剂的结合位点。
• IMBERT, T.;DOSTERT, P.;LANGLOIS, M.
  作者：IMBERT, T.、DOSTERT, P.、LANGLOIS, M.

  DOI：——

  日期：——
• Potential antipsychotic agents. 6. Synthesis and antidopaminergic properties of substituted N-(1-benzyl-4-piperidinyl)salicylamides and related compounds. QSAR based design of more active members
  作者：T de Paulis、H Hall、Y Kumar、S Rämsby、SO Ögren、T Högberg

  DOI：10.1016/0223-5234(90)90145-s

  日期：1990.7
• Fluorine-18 labeled benzamides for studying the dopamine D2 receptor with positron emission tomography
  作者：Robert H. Mach、Robert R. Leudtke、Christopher D. Unsworth、Virginia A. Boundy、Peggy A. Nowak、James G. Scripko、S. Todd Elder、Joseph R. Jackson、Patricia L. Hoffman

  DOI：10.1021/jm00075a028

  日期：1993.11

  Two series of (N-benzylpiperidin-4-yl)- and (9-azabicyclo[3.3.1]nonan-3beta-yl)benzamides were prepared, and in vitro binding assays were used to measure the affinity of these compounds for dopamine D2, dopamine D3, serotonin 5-HT2, and alpha2-adrenergic receptors. The results of these studies indicated compounds 23, 26b, and 34 have the selectivity needed for in vivo studies of the D2 (and possibly D3) receptors. F-18-Labeled analogues of 23, 26b and 34 were prepared by N-alkylation of the corresponding desbenzyl precursors with [F-18]-4-fluorobenzyl iodide. Preliminary in vivo studies demonstrated that [F-18]-23 and [F-18]-26b are suitable candidates for further evaluation in positron emission tomography imaging studies. The slow rate of washout of [F-18]-34 from nondopaminergic regions and its comparatively high lipophilicity indicates that this compound may not be suitable for imaging studies because of a high level of nonspecific binding.